Sandbox MWH

Revision as of 16:12, 14 August 2020 by Waleed Haider (talk | contribs)
Jump to navigation Jump to search


Year Discovery
1877
  • First-ever description of narcolepsy in the medical literature
1880
  • Gelineau named the disorder “narcolepsy”
1902
  • Loewenfeld first coined the term “cataplexy”
1935
  • First-ever use of amphetamines in the treatment of narcolepsy
1960
  • Description of Sleep Onset REM in patients with narcolepsy
1970
  • Multiple Latency Test description
1973
  • First-ever report of narcolepsy in a canine
1983
  • Association of HLA-DR2 with narcolepsy
1992
  • Association of HLA-DQB1*0602 with narcolepsy
1998
  • Hypocretins (orexins) and their receptors identification
2000
  • Association between Human narcolepsy and hypocretin deficiency


Table 1: A few milestones in narcolepsy research and therapy 1877 First description in the medical literature (100) 1880 Gelineau called the disorder “narcolepsy” (28) 1902 Loewenfeld coined the term “cataplexy” (53) 1935 First use of amphetamines in the treatment of narcolepsy (87) 1960 Description of Sleep Onset REM periods in a narcoleptic subject (99) 1970 Description of the Multiple Latency Test (15, 90) 1973 First report of a narcoleptic dog (47, 72) 1983 Association of narcolepsy with HLA-DR2 (37) 1985 Monoaminergic and cholinergic imbalance in narcolepsy (7, 80) 1992 Association of narcolepsy with HLA-DQB1*0602 (56, 63) 1998 Identification of hypocretins/orexins and their receptors (18, 93) 1999 Hypocretin mutations cause narcolepsy in mice and dogs (16, 51) 2000 Human narcolepsy is also associated with an hypocretin deficiency (81)